FDA puts a hold on Molecular Templates' PhI trial for cancer drug
A Phase I trial for one of the penny stock Molecular Templates’ drug candidates has been given a clinical hold by the FDA.
The drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
